Biotinylated Mouse CD27 Ligand / CD70 Protein, His,Avitag™

Proteins and Peptides

貨號 Cat. No.
CDL-M82Qb
規格 Size
200ug
品牌 Brand
ACROBiosystems
Species
Mouse
Conjugate
Precision Avi
Expression System
HEK293
Tag
Avi Tag 、 His Tag

Description




Source : 


Biotinylated Mouse CD27 Ligand, His,Avitag (CDL-M82Qb) is expressed from human 293 cells (HEK293). It contains AA Gln 47 - Pro 195 (Accession # O55237-1).


 

Molecule : CD27 Ligand


 

Synonyms : CD70,CD27LG,TNFSF7,TNFSF7G,CD27L


 

Format : Powder


 

Category : MABSol® Biotin Labeled Proteins


 

Accession :  NP_035747.1


 

Storage : -20℃


 

Shipping condition : Powder,RT


 

Molecular Weight : 20.1 kDa


 

Characteristics :


This protein carries a polyhistidine tag at the N-terminus, followed by an Avi tag (Avitag™). The protein has a calculated MW of 20.1 kDa. The protein migrates as 28-32 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.


 

Endotoxin Level : Less than 1.0 EU per μg by the LAL method.


 

Buffer : PBS, pH7.4


 

Description :


Cluster of Differentiation 70 (CD70) is also known as CD27 ligand (CD27L / CD27LG), TNFSF7, TNFSF7G, is a type II transmembrane glycoprotein belonging to the TNF superfamily (TNFSF) and is a surface antigen found on activated T-and B-lymphocytes and mature dendritic cells. Binding of CD70 to its receptor CD27 induces in priming, effector functions, differentiation and memory formation of T-cells, and thus is invloved in the biological processes including T-cell activation, the proliferation of costimulated T-cells, as well as the generation of cytolytic T-cells. CD70 on T cells provides costimulatory signals that are required for T cell proliferation, clonal expansion and the promotion of effector T cell formation. CD70 on mouse B cell has been shown to inhibit terminal differentiation of activated B cells into plasma cells and enhances commitment to memory B cell responses. CD70 induces proliferation and IFNγ production, on NK cells.


 

References :


(1) McEarchern JA. et al., 2008, Clin Cancer Res., 14(23):7763-72.
(2) Croft M., 2003, Nat Rev Immunol., 3(8):609-20.
(3) Kobata, TS. et al., 1995, Proc. Natl. Acad. Sci. USA, 92: 11249–11253.
(4) Raman V.S. et al., 2003, J Immunol., 171(11):5876-81.
(5) Takeda, K. et al., 2000, J Immunol., 15;164(4):1741-5.





詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢